A Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets in Subjects With Type 2 Diabetes Mellitus
Public ClinicalTrials.gov record NCT02390050. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Multi-center, Double-blind, Placebo-controlled, Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets on HbA1c in Subjects With Type 2 Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study was to investigate the effect of bexagliflozin in lowering hemoglobin A1c (HbA1c) levels in patients with type 2 diabetes mellitus (T2DM). Bexagliflozin is an orally administered drug for the treatment of T2DM and is classified as a Sodium Glucose co-Transporter 2 (SGLT2) Inhibitor. This study was to enroll both treatment naive and those subjects previously treated with one oral hypoglycemic agent (OHA). Approximately 320 subjects eligible for randomization was to receive bexagliflozin tablets, 5, 10, 20 mg or placebo, once daily for 12 weeks in an outpatient setting.
Study identification
- NCT ID
- NCT02390050
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 292 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 20 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 11, 2015
- Primary completion
- Jun 2, 2016
- Completion
- Jun 2, 2016
- Last update posted
- Jun 28, 2021
2015 – 2016
United States locations
- U.S. sites
- 32
- U.S. states
- 14
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Phoenix Medical Research Institute LLC | Peoria | Arizona | 85381 | — |
| Advanced Arizona Clinical Research | Tucson | Arizona | 85712 | — |
| Hope Clinical Research, LLC | Canoga Park | California | 91303 | — |
| Catalina Research Institute | Chino | California | 91710 | — |
| National Research Institute | Huntington Park | California | 90255 | — |
| Long Beach Clinical Trials | Long Beach | California | 90806 | — |
| Synergy San Diego | National City | California | 91950 | — |
| Northern California Research | Sacramento | California | 95821 | — |
| Artemis Institute for Clinical Research, LLC | San Diego | California | 92103 | — |
| Infosphere Clinical Research, Inc | West Hills | California | 91307 | — |
| M&O Clinical Research LLC | Fort Lauderdale | Florida | 33316 | — |
| AGA Clinical Trials | Hialeah | Florida | 33012 | — |
| Compass Research North | Leesburg | Florida | 34748 | — |
| Sweet Hope Research Specialty, Inc | Miami Lakes | Florida | 33016 | — |
| Sunshine Research Center | Opa-locka | Florida | 33054 | — |
| Compass Research LLC | Orlando | Florida | 32806 | — |
| Progressive Medical Research | Port Orange | Florida | 32127 | — |
| PICR Clinic | Atlanta | Georgia | 30338 | — |
| Sundance Clinical Research | St Louis | Missouri | 63141 | — |
| Premier Research Ltd | Trenton | New Jersey | 08611 | — |
| Regional Clinical Research, Inc | Endwell | New York | 13760 | — |
| Calabash Medical Center | Calabash | North Carolina | 28467 | — |
| Diabetes & Endocrinology Consultants PC | Morehead City | North Carolina | 28557 | — |
| PMG Research of Salisbury | Salisbury | North Carolina | 28144 | — |
| CTI Research | Cincinnati | Ohio | 45255 | — |
| Summit Research Group, LLC | Stow | Ohio | 44224 | — |
| Columbia Research Group, Inc. | Portland | Oregon | 97239 | — |
| Detweiler Family Medicine and Associate, P.C. | Lansdale | Pennsylvania | 19446 | — |
| North Myrtle Beach Family Practice | Myrtle Beach | South Carolina | 29582 | — |
| Global Medical Research | DeSoto | Texas | 75115 | — |
| Rockwood Medical Clinic | Fort Worth | Texas | 76164 | — |
| Wasatch Clinical Research | Salt Lake City | Utah | 84107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02390050, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 28, 2021 · Synced Sep 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02390050 live on ClinicalTrials.gov.